Skip to Main Content

Rapid Case Ascertainment Shared Resource

July 24, 2026

Working as an agent of the Connecticut Tumor Registry, the Rapid Case Ascertainment (RCA) Shared Resource facilitates population-based studies of cancer for YCC investigators as well as outside investigators.

Contact

Rajni Mehta, MPH, Director

rajni.mehta@yale.edu

    ID
    14354

    Transcript

    • 00:00Hi, everybody. I am Raj
    • 00:02Nimehta. I'm the director of
    • 00:04the rapid case ascertainment
    • 00:06shared resource.
    • 00:08And
    • 00:09next slide, please.
    • 00:11So
    • 00:12the rapid case ascertainment resource
    • 00:14is a little different from
    • 00:16probably what you've heard,
    • 00:17because we we work with
    • 00:20investigators conducting
    • 00:21non therapeutic studies. So you
    • 00:23can think of us as
    • 00:25you can think of the
    • 00:26clinical trials office as the
    • 00:28therapeutic,
    • 00:30resource,
    • 00:31and we are the non
    • 00:32therapeutic. So we support,
    • 00:35cancer center members
    • 00:37in,
    • 00:38in studies that are non
    • 00:39therapeutic for case identification,
    • 00:42study management, patient enrollment, medical
    • 00:45record abstraction,
    • 00:47and specimen collection so they
    • 00:49can accomplish their scientific goals.
    • 00:52Next slide.
    • 00:55So we have been a
    • 00:57YCC shared resource since nineteen
    • 00:59ninety five,
    • 01:01and we wear several different
    • 01:03hats. Right? So we we
    • 01:05work as Yale staff to
    • 01:07support Yale studies, but we
    • 01:09also work,
    • 01:12as agents of the Connecticut
    • 01:13Tumor Registry through a personal
    • 01:15service agreement
    • 01:17so we can collect data
    • 01:18from
    • 01:19outside
    • 01:20hospitals that are not Yale.
    • 01:22So that's kind of our
    • 01:23Connecticut Tumor Registry hat.
    • 01:26So in in this personal
    • 01:28service agreement, after we get
    • 01:30all the approvals,
    • 01:31we can assist investigators
    • 01:34in identifying cases and collecting
    • 01:36specimens from,
    • 01:39Connecticut hospitals for our for
    • 01:41through the Connecticut Tumor Registry.
    • 01:45The cost of RCA
    • 01:47is is really the staff
    • 01:49time and effort. Right? We
    • 01:51we don't have any machines
    • 01:53or we don't have any
    • 01:54equipment. We just charge
    • 01:56for our time and effort
    • 01:59devoted
    • 02:00to what we do for
    • 02:01each investigator,
    • 02:02and we do that in
    • 02:03two ways. So we have
    • 02:04our current,
    • 02:07way of one hundred and
    • 02:08forty dollars an hour, and
    • 02:09that's a fee for service.
    • 02:11And as a cancer center
    • 02:12member,
    • 02:13you get, a fifteen percent,
    • 02:15discount
    • 02:16on that. So it's a
    • 02:17the cancer center pays fifteen
    • 02:19percent of that. So you're
    • 02:20only charged for the eighty,
    • 02:23eighty five percent.
    • 02:25And then another way that
    • 02:27we recover costs is that
    • 02:30some of our staff are
    • 02:31dedicated
    • 02:32to your study
    • 02:34as a percent effort. So
    • 02:36many studies
    • 02:37cannot,
    • 02:38hire a full time person.
    • 02:40So if you can hire
    • 02:41your full time person, great.
    • 02:43You can go and hire
    • 02:44them. But many
    • 02:45of our studies are smaller,
    • 02:47and investigators
    • 02:48only have, like, let's say,
    • 02:49a twenty percent effort or
    • 02:50a ten percent effort. So
    • 02:52that's where we can come
    • 02:53in,
    • 02:54and you can hire somebody
    • 02:56at that
    • 02:57small effort to help you,
    • 02:59and you don't have to
    • 03:00hire somebody because you could
    • 03:02never,
    • 03:03hire somebody at that, level
    • 03:05of effort. So that's how,
    • 03:07some of our staff, you
    • 03:08know, work twenty percent on
    • 03:10one study, twenty percent on
    • 03:11another study. So so it
    • 03:12really helps these smaller
    • 03:14investigators who do not have
    • 03:16a lot of money,
    • 03:17be able to conduct their
    • 03:19studies. Because if if, of
    • 03:21course, if you have a
    • 03:22full time FTE, then it's
    • 03:23great. You have somebody dedicated,
    • 03:25but we can help you
    • 03:26in that way.
    • 03:29In in addition to the
    • 03:31dedicated effort, just being able
    • 03:32to charge you by the
    • 03:33hour is something that some
    • 03:35investigators like because you don't
    • 03:37you only need a certain,
    • 03:39let's say, hundred records extracted.
    • 03:41Right? So we just say,
    • 03:42okay. Can you extract a
    • 03:44hundred records for us? We
    • 03:45don't
    • 03:46it could take us, you
    • 03:47know, a couple of months,
    • 03:48but we just pay you
    • 03:50by the hour that we
    • 03:51work on your study.
    • 03:53So those are the the
    • 03:54two different ways.
    • 03:55Next slide.
    • 03:57And so, again, these are
    • 03:58our key services
    • 04:00that we perform. We have
    • 04:01a lot of experience with
    • 04:03IRB approvals,
    • 04:05overall study management.
    • 04:07You know, people come to
    • 04:08me to say, oh, how
    • 04:09do I get this DUA
    • 04:10done?
    • 04:12Can you help me?
    • 04:13How do I pay sites?
    • 04:15Can you help me pay
    • 04:16sites? And and so these
    • 04:17are just,
    • 04:18staff,
    • 04:19you know, activities that that
    • 04:21people need help with. We
    • 04:23identify
    • 04:24cancer cases. So if you
    • 04:26say
    • 04:27you need to identify everybody
    • 04:29with liver cancer because you
    • 04:30wanna do a study,
    • 04:32and abstract treatment on liver
    • 04:34cancer, so we can help
    • 04:36you with that.
    • 04:37Again, extracting medical records. Many
    • 04:39of our,
    • 04:42you know, the IRB protocols
    • 04:43require physician consent. So we
    • 04:46help investigators
    • 04:47identify the patients and then
    • 04:48contacting these the their their
    • 04:51clinicians for permission to contact
    • 04:53them. We screen them. We
    • 04:55conduct surveys either in person
    • 04:57or,
    • 04:58sending them a link. We
    • 05:00also collect
    • 05:02blood,
    • 05:03specimens during their standard of
    • 05:05care collection. Some some
    • 05:07investigators,
    • 05:10wanna collect an additional tube
    • 05:11of blood
    • 05:12from these, patients that are
    • 05:14getting certain treatments
    • 05:16or,
    • 05:17you know, the COVID vaccine.
    • 05:19They wanna test, you know,
    • 05:21markers, and so we have
    • 05:23done that as well.
    • 05:25Same thing for stool and
    • 05:26CSF.
    • 05:27And we also work with
    • 05:29archival pathology specimens.
    • 05:32We work with Yale New
    • 05:34Haven Hospital with,
    • 05:35the shared resource also, and
    • 05:38we work collecting specimens from
    • 05:40all over the country.
    • 05:43Cohorts, for example, everybody who's
    • 05:45who has,
    • 05:46had, like,
    • 05:48liver cancer,
    • 05:49through the VA, for example.
    • 05:51We've done a study where
    • 05:53we collected from all the
    • 05:54stations at the VA for
    • 05:56patients who had liver cancer.
    • 05:58And then it was brought
    • 05:59you know, they shipped the
    • 06:00specimens. We we worked with
    • 06:02the l pathology
    • 06:03to section them with our
    • 06:04study pathologist,
    • 06:06and then we returned these
    • 06:07specimens.
    • 06:09We also serve as honest
    • 06:11brokers, which means that some
    • 06:13studies that the investigator has
    • 06:15to be blinded.
    • 06:16We're able to be that
    • 06:18person who that the the
    • 06:20the shared resource who knows
    • 06:21who these patients are to
    • 06:23be able to collect the
    • 06:24specimens. But when
    • 06:26we give it to the
    • 06:26investigator, it's de identified.
    • 06:29So the IRBs will usually,
    • 06:32exempt those studies because you're
    • 06:34not collecting any identifiers.
    • 06:36You you we are your
    • 06:38middle person, your honest broker
    • 06:40to know.
    • 06:41We know who they are
    • 06:42to collect the data, but
    • 06:43you are not getting anything.
    • 06:45And, again, some of the
    • 06:46other things that we've done
    • 06:48is collecting films,
    • 06:49radiology scans. So we work
    • 06:51with investigators.
    • 06:53If they wanna collect anything,
    • 06:55we we can help you
    • 06:57and and kinda brainstorm how
    • 06:58to do this.
    • 06:59Next slide.
    • 07:01So this is just a
    • 07:03really quick example of the
    • 07:05studies that we've done.
    • 07:08So prospective identification
    • 07:10with surveys and pathology collections.
    • 07:12These, again, newly diagnosed.
    • 07:15We do you know, I've
    • 07:17talked a little bit about
    • 07:18this where we can,
    • 07:20we can consent the patient.
    • 07:22We can collect,
    • 07:23some a survey. We can
    • 07:25collect their specimens.
    • 07:28We do this, again, also
    • 07:29retrospectively.
    • 07:30Like, there's a a retrospective
    • 07:32cohort of ten years of,
    • 07:34let's say,
    • 07:36brain tumors,
    • 07:38and we can go back
    • 07:39and do a whole medical
    • 07:40record abstraction, collect their slide
    • 07:42their blocks,
    • 07:44collect imaging, everything.
    • 07:47Number three is, again, our
    • 07:48our work with our connect
    • 07:50with the Connecticut Tumor Registry.
    • 07:51This is like our our
    • 07:53kinda Connecticut Tumor Registry hat
    • 07:55a little bit differently than
    • 07:56as working as a Yale
    • 07:58employee.
    • 08:00And we we can collect,
    • 08:02specimens, medical record abstraction
    • 08:06for,
    • 08:07any, you know, any patient
    • 08:09diagnosed in Connecticut.
    • 08:11As you know,
    • 08:12any cancer diagnosis is reportable
    • 08:15to the Connecticut Tumor Registry,
    • 08:16so they
    • 08:18have everybody who's been diagnosed
    • 08:20with cancer. It's the oldest,
    • 08:22tumor registry in the country.
    • 08:25And then, again, our, like
    • 08:27I've said before, we also
    • 08:28can collect,
    • 08:30blood, stools. We've done some
    • 08:31of these,
    • 08:33CSF collections that investigators need.
    • 08:35We we bring the tubes,
    • 08:37and then when they're getting
    • 08:38their CSF or their biopsy,
    • 08:40we then,
    • 08:41transport that back to the
    • 08:43lab that's gonna be,
    • 08:46analyzing that.
    • 08:48Next slide.
    • 08:51So just I've touched a
    • 08:52little bit about this, but
    • 08:53the benefits
    • 08:54is that we we have
    • 08:57a lot of experience.
    • 08:59I've been this I've been
    • 09:00doing this for twenty five
    • 09:01years in this position. We
    • 09:03have Rocco who's been here
    • 09:04for thirty five years, forty
    • 09:06years.
    • 09:08So we we've have a
    • 09:10lot of experience in in
    • 09:12lab experience
    • 09:13and IRB experience. We're very
    • 09:15flexible.
    • 09:17I usually meet with every
    • 09:19investigator that wants to use
    • 09:21RCA just to kinda guide
    • 09:22them. You don't have to
    • 09:23use me. A lot of
    • 09:24times, they're like, oh, thank
    • 09:25you for letting me know
    • 09:26I could do this. So
    • 09:27I'm here just for to
    • 09:29also provide guidance,
    • 09:30through study planning,
    • 09:33just to give you just,
    • 09:35ideas and how to better
    • 09:37do your study. If you
    • 09:38don't have any funding, I've
    • 09:39still I can still help
    • 09:40you. You know, I'm happy
    • 09:41to meet with anybody
    • 09:43just to guide you on
    • 09:44what you need to do.
    • 09:45I do this all the
    • 09:46time. How do I apply
    • 09:47for IRB?
    • 09:49So I'm here to, you
    • 09:50know, support anybody here at
    • 09:52the cancer center.
    • 09:54Next slide.
    • 09:56So here's my email.
    • 09:58Please feel free to reach
    • 09:59out,
    • 10:01and I can, you know,
    • 10:02try to help you in
    • 10:03any way I can.